{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:49:32Z","timestamp":1791521372022,"version":"4.3.4"},"reference-count":147,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Invasive group A streptococcal (iGAS) infections in children, although rare, are associated with significant morbidity and mortality, and their incidence has risen globally in recent years. Evidence for optimal management in children is limited. These guidelines aim to provide evidence-based recommendations for the management of pediatric iGAS, including antibiotic therapy, adjunctive nonantibiotic therapies and prophylaxis of close contacts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The ESPID Guidelines Committee convened a multidisciplinary working group. A systematic literature search of pediatric studies published from 2003 to 2023 in PubMed, Embase and the Cochrane Library was performed. Clinical questions with pediatric data were formulated as PICO and assessed using the GRADE approach, with consensus achieved through a modified Delphi process. For clinically important questions lacking sufficient evidence, narrative synthesis with nongraded expert consensus was used. Additional publications until August 2025 contributed qualitatively but were not formally GRADE-graded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Penicillins remain the first-line therapy for iGAS. In severe or toxin-mediated infections (eg, necrotizing fasciitis or streptococcal toxic shock syndrome), adjunctive clindamycin is suggested, with linezolid as an alternative where clindamycin resistance is confirmed or in central nervous system disease. Intravenous immunoglobulin may be considered in life-threatening toxin-mediated disease, whereas evidence for corticosteroids is insufficient. Prophylaxis is recommended for high-risk household contacts (neonates, postpartum women, elderly, immunocompromised, and recent varicella infection) and considered for all contacts in outbreak settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These ESPID guidelines provide evidence-based recommendations for the management of pediatric iGAS. Given the rarity and limited trial data, most recommendations are weak and supported by low-quality evidence, highlighting the need for high-quality pediatric studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005336","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:00:27Z","timestamp":1785902427000},"page":"e457-e470","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Management of Invasive Group A Streptococcal Infections in Children"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1476-4752","authenticated-orcid":false,"given":"Elena","family":"Chiappini","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Meyer Children\u2019s University Hospital IRCCS, Florence, Italy"},{"name":"Department of Health Science, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-6621","authenticated-orcid":false,"given":"Roberta","family":"Pellegrino","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Meyer Children\u2019s University Hospital IRCCS, Florence, Italy"},{"name":"Department of Health Science, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Dalpiaz","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Meyer Children\u2019s University Hospital IRCCS, Florence, Italy"},{"name":"Department of Health Science, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7946-5829","authenticated-orcid":false,"given":"Marco","family":"Renni","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Meyer Children\u2019s University Hospital IRCCS, Florence, Italy"},{"name":"Department of Health Science, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-0328","authenticated-orcid":false,"given":"Eleni","family":"Vergadi","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, School of Medicine, University of Crete, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Ivaska","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland"},{"name":"InFLAMES Research Flagship Center, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Romani","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-3544","authenticated-orcid":false,"given":"Gulhadiye","family":"Avcu","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Pediatrics, Medical School of Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-4254","authenticated-orcid":false,"given":"Gregorio","family":"Milani","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"},{"name":"Department of Clinical Sciences and Community Health, Universit\u00e0 Degli Studi Di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-3871","authenticated-orcid":false,"given":"Dana","family":"Danino","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Saban Children Hospital, Soroka University Medical Center, Beer Sheva, Israel"},{"name":"Faculty of Health Sciences, Joyce & Irving Goldman Medical School, Ben Gurion University of the Negev, Beer-Sheva, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00431-023-04967-5","article-title":"Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain.","volume":"182","author":"Cobo-V\u00e1zquez","year":"2023","journal-title":"Eur J Pediatr"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/INF.0000000000000587","article-title":"Group A streptococcal bacteremia without a source is associated with less severe disease in children.","volume":"34","author":"Gauguet","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1473-3099(21)00672-1","article-title":"Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis.","volume":"22","author":"Sherwood","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/archdischild-2013-304741","article-title":"Toxic shock syndrome surveillance in UK children.","volume":"99","author":"Adalat","year":"2014","journal-title":"Arch Dis Child"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/iai.61.3.793-799.1993","article-title":"Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.","volume":"61","author":"Bonventre","year":"1993","journal-title":"Infect Immun"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000441-199601000-00008","article-title":"The reemergence of serious group A streptococcal infections and acute rheumatic fever.","volume":"311","author":"Bronze","year":"1996","journal-title":"Am J Med Sci"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe.","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1186\/s12889-019-8085-2","article-title":"Invasive group A streptococcus disease in Australian children: 2016 to 2018\u2014a descriptive cohort study.","volume":"19","author":"Oliver","year":"2019","journal-title":"BMC Public Health"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"ofy177","DOI":"10.1093\/ofid\/ofy177","article-title":"Increasing rates of invasive group A streptococcal disease in Alberta, Canada; 2003-2017.","volume":"5","author":"Tyrrell","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1473-3099(17)30693-X","article-title":"Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study.","volume":"18","author":"Lamagni","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"2200941","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200941","article-title":"Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022.","volume":"28","author":"de Gier","year":"2023","journal-title":"Euro Surveill"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/INF.0000000000004746","article-title":"Changes in epidemiology in pediatric invasive group A streptococcal infections in Ireland during the 2022-2023 outbreak.","volume":"44","author":"Foley","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"2200942","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942","article-title":"Increase in invasive group A streptococcal infection notifications, England, 2022.","volume":"28","author":"Guy","year":"2023","journal-title":"Euro Surveill"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"2300291","DOI":"10.2807\/1560-7917.ES.2023.28.26.2300291","article-title":"Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023.","volume":"28","author":"Johannesen","year":"2023","journal-title":"Euro Surveill"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/JCM.43.4.1678-1683.2005","article-title":"Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002).","volume":"43","author":"Tyrrell","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/INF.0000000000003810","article-title":"Increase in invasive group A streptococcal infections in children in the Netherlands, a survey among 7 hospitals in 2022.","volume":"42","author":"van Kempen","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/pathogens13111007","article-title":"Group A streptococcus infections in children: epidemiological insights before and after the COVID-19 pandemic.","volume":"13","author":"Karapati","year":"2024","journal-title":"Pathogens"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"e0072923","DOI":"10.1128\/msphere.00729-23","article-title":"Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak.","volume":"9","author":"Ram\u00edrez de Arellano","year":"2024","journal-title":"mSphere"},{"key":"R24-20261009","first-page":"100873","article-title":"Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges.","volume":"41","author":"Abo","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm7210a4","article-title":"Notes from the field: increase in pediatric invasive group A streptococcus infections\u2014Colorado and Minnesota, October-December 2022.","volume":"72","author":"Barnes","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3201\/eid3011.241068","article-title":"Invasive group A streptococcus hypervirulent M1UK clone, Canada, 2018-2023.","volume":"30","author":"Golden","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"e0076624","DOI":"10.1128\/jcm.00766-24","article-title":"Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study.","volume":"62","author":"R\u00fcmke","year":"2024","journal-title":"J Clin Microbiol"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-024-47929-7","article-title":"Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes.","volume":"15","author":"Vieira","year":"2024","journal-title":"Nat Commun"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cmi.2023.03.001","article-title":"The ongoing Streptococcus pyogenes (group A streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study.","volume":"29","author":"Alcolea-Medina","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.2025.0910","article-title":"Invasive group A streptococcal infections in 10 US States.","volume":"333","author":"Gregory","year":"2025","journal-title":"JAMA"},{"key":"R31-20261009","first-page":"101467","article-title":"Genomic interrogation of invasive group A streptococcus (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective study.","volume":"55","author":"Morris","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"107982","DOI":"10.1016\/j.ijid.2025.107982","article-title":"Sharp increase in the incidence and severity of invasive Streptococcus pyogenes infections in children after the COVID-19 pandemic (2019-2023): a nationwide multicenter study.","volume":"159","author":"Cobo-V\u00e1zquez","year":"2025","journal-title":"Int J Infect Dis"},{"key":"R33-20261009","doi-asserted-by":"crossref","first-page":"e252861","DOI":"10.1001\/jamanetworkopen.2025.2861","article-title":"Invasive group A streptococcal infection in Children, 1992-2023.","volume":"8","author":"Dabaja-Younis","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R34-20261009","doi-asserted-by":"crossref","first-page":"2300739","DOI":"10.2807\/1560-7917.ES.2024.29.40.2300739","article-title":"Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023.","volume":"29","author":"de Gier","year":"2024","journal-title":"Euro Surveill"},{"key":"R35-20261009","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/INF.0000000000004855","article-title":"National 10-year cohort study of life-threatening invasive group A streptococcal infection in children, 2013-2023.","volume":"44","author":"Holdstock","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2352-4642(23)00295-X","article-title":"Invasive group A streptococcal infections in children and adolescents in Denmark during 2022-23 compared with 2016-17 to 2021-22: a nationwide, multicentre, population-based cohort study.","volume":"8","author":"Nygaard","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s15010-024-02198-w","article-title":"Preadmission course and management of severe pediatric group A streptococcal infections during the 2022-2023 outbreak: a single-center experience.","volume":"52","author":"Sch\u00f6bi","year":"2024","journal-title":"Infection"},{"key":"R38-20261009","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1542\/peds.105.5.e60","article-title":"Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario group A streptococcal study group.","volume":"105","author":"Laupland","year":"2000","journal-title":"Pediatrics"},{"key":"R39-20261009","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1542\/peds.107.5.1108","article-title":"Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella.","volume":"107","author":"Lesko","year":"2001","journal-title":"Pediatrics"},{"key":"R40-20261009","first-page":"1472","article-title":"State of the art of invasive group A streptococcus infection in children: a scoping review of the literature with a focus on predictors of invasive infection.","volume":"10","author":"Mariani","year":"2023","journal-title":"Children (Basel)"},{"key":"R41-20261009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/INF.0b013e318195bb10","article-title":"Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children.","volume":"28","author":"Minodier","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R42-20261009","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jpids\/piz013","article-title":"Invasive group A streptococcus infection in children in Southern Israel before and after the introduction of varicella vaccine.","volume":"9","author":"Hasin","year":"2020","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"R43-20261009","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3201\/eid1107.040900","article-title":"Risk factors for pediatric invasive group A streptococcal disease.","volume":"11","author":"Factor","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R44-20261009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","article-title":"Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice.","volume":"13","author":"Eagle","year":"1952","journal-title":"Am J Med"},{"key":"R45-20261009","first-page":"269","article-title":"Clindamycin affects group A streptococcus virulence factors and improves clinical outcome.","volume":"215","author":"Andreoni","year":"2017","journal-title":"J Infect Dis"},{"key":"R46-20261009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","article-title":"The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.","volume":"158","author":"Stevens","year":"1988","journal-title":"J Infect Dis"},{"key":"R47-20261009","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R48-20261009","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group a streptococcal disease: epidemiology, pathogenesis and management.","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"issue":"Suppl 1","key":"R49-20261009","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.jinf.2014.08.005","article-title":"Management of invasive group A streptococcal infections.","volume":"69","author":"Waddington","year":"2014","journal-title":"J Infect"},{"key":"R51-20261009","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/pch\/pxz039","article-title":"Invasive group A streptococcal disease: management and chemoprophylaxis.","volume":"24","author":"Moore","year":"2019","journal-title":"Paediatr Child Health"},{"issue":"Suppl 2","key":"R53-20261009","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0929-693X(14)72267-5","article-title":"[Management of severe invasive group A streptococcal infections].","volume":"21","author":"Faye","year":"2014","journal-title":"Arch Pediatr"},{"key":"R54-20261009","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/40.2.275","article-title":"Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes.","volume":"40","author":"Sriskandan","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"R56-20261009","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R57-20261009","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1 Pt 1","key":"R61-20261009","first-page":"136","article-title":"Severe invasive group A streptococcal infections: a subject review.","volume":"101","year":"1998","journal-title":"Pediatrics"},{"key":"R62-20261009","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0009922807299940","article-title":"Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature.","volume":"46","author":"Burnett","year":"2007","journal-title":"Clin Pediatr (Phila)"},{"key":"R63-20261009","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1592\/phco.23.5.638.32191","article-title":"Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Insights from the society of infectious diseases pharmacists.","volume":"23","author":"Coyle","year":"2003","journal-title":"Pharmacotherapy"},{"key":"R64-20261009","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/INF.0000000000002524","article-title":"A pharmacoepidemiologic study of the safety and effectiveness of clindamycin in infants.","volume":"39","author":"Greenberg","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R65-20261009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jpids\/piy062","article-title":"Increasing clindamycin and trimethoprim-sulfamethoxazole resistance in pediatric Staphylococcus aureus infections.","volume":"8","author":"Khamash","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R66-20261009","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30523-5","article-title":"Effectiveness of adjunctive clindamycin in \u03b2-lactam antibiotic-treated patients with invasive \u03b2-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.","volume":"21","author":"Babiker","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R67-20261009","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s15010-024-02413-8","article-title":"Post-COVID-19-pandemic changes and clinical characteristics of invasive group a streptococcal infections from 2015 to 2023.","volume":"53","author":"Tomidis Chatzimanouil","year":"2025","journal-title":"Infection"},{"key":"R68-20261009","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R69-20261009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.anpedi.2016.10.001","article-title":"[Toxic shock syndrome in a paediatric intensive care unit over the last 15 years].","volume":"87","author":"Butrague\u00f1o Laiseca","year":"2017","journal-title":"An Pediatr (Barc)"},{"key":"R70-20261009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5152\/TurkArchPediatr.2022.21221","article-title":"Clinical and laboratory features of invasive group A streptococcal infections: 8 years experience.","volume":"57","author":"\u015eahin","year":"2022","journal-title":"Turk Arch Pediatr"},{"key":"R71-20261009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/INF.0000000000000945","article-title":"Invasive group A streptococcal infections in children: a nationwide survey in Finland.","volume":"35","author":"Tapiainen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R72-20261009","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3201\/eid2911.230211","article-title":"Group A streptococcus primary peritonitis in children, New Zealand.","volume":"29","author":"Taylor","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"R73-20261009","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3345\/cep.2025.00479","article-title":"Evolving treatment strategies for invasive Streptococcus pyogenes in children in the postpandemic era.","volume":"68","author":"Buricchi","year":"2025","journal-title":"Clin Exp Pediatr"},{"key":"R74-20261009","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"R75-20261009","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R76-20261009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jac\/dku379","article-title":"Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis.","volume":"70","author":"Nemeth","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R77-20261009","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/cid\/cix1127","article-title":"Busting the myth of \u201cstatic vs cidal\u201d: a systemic literature review.","volume":"66","author":"Wald-Dickler","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R78-20261009","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/597582","article-title":"Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis.","volume":"48","author":"Peltola","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R79-20261009","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1469-0691.2011.03643.x","article-title":"Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood\u2014a prospective quasi-randomized controlled trial.","volume":"18","author":"Peltola","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R80-20261009","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1403789","article-title":"Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.","volume":"372","author":"Miller","year":"2015","journal-title":"N Engl J Med"},{"key":"R81-20261009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/JAA.S242061","article-title":"\u03b2-Lactam allergy and cross-reactivity: a clinician\u2019s guide to selecting an alternative antibiotic.","volume":"14","author":"Caruso","year":"2021","journal-title":"J Asthma Allergy"},{"key":"R82-20261009","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.14122","article-title":"Towards a more precise diagnosis of hypersensitivity to beta-lactams\u2014an EAACI position paper.","volume":"75","author":"Romano","year":"2020","journal-title":"Allergy"},{"key":"R83-20261009","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1128\/AAC.42.11.3014","article-title":"Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS.","volume":"42","author":"Gatti","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R84-20261009","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3171\/jns.1975.43.6.0717","article-title":"Clindamycin concentrations in the central nervous system of primates before and after head trauma.","volume":"43","author":"Picardi","year":"1975","journal-title":"J Neurosurg"},{"key":"R85-20261009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinthera.2010.01.019","article-title":"Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review.","volume":"32","author":"Chiappini","year":"2010","journal-title":"Clin Ther"},{"key":"R86-20261009","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/jac\/dkr285","article-title":"Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases.","volume":"66","author":"Garazzino","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"9 Suppl","key":"R87-20261009","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1097\/01.inf.0000087022.58089.d8","article-title":"Safety and tolerability of linezolid in children.","volume":"22","author":"Saiman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R88-20261009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/pathogens14010004","article-title":"Therapeutic drug monitoring-guided linezolid therapy for the treatment of multiple staphylococcal brain abscesses in a 3-month-old infant.","volume":"14","author":"Cascone","year":"2024","journal-title":"Pathogens"},{"key":"R89-20261009","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S1413-86702007000200027","article-title":"Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child.","volume":"11","author":"da Silva","year":"2007","journal-title":"Braz J Infect Dis"},{"key":"R90-20261009","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2008.06.023","article-title":"Glycopeptide insensitive staphylococcus aureus subdural empyema treated with linezolid and rifampicin.","volume":"57","author":"Gallagher","year":"2008","journal-title":"J Infect"},{"key":"R91-20261009","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/microorganisms13051100","article-title":"Unraveling pediatric group A streptococcus meningitis: lessons from two case reports and a systematic review.","volume":"13","author":"Di Meglio","year":"2025","journal-title":"Microorganisms"},{"key":"R92-20261009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijid.2022.12.015","article-title":"The efficacy and safety of a shortened duration of antimicrobial therapy for group A streptococcus bacteremia.","volume":"128","author":"Nguyen","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R93-20261009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13613-024-01249-7","article-title":"Clinical and molecular epidemiological features of critically ill patients with invasive group A streptococcus infections: a Belgian multicenter case-series.","volume":"14","author":"Peetermans","year":"2024","journal-title":"Ann Intensive Care"},{"key":"R94-20261009","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jpids\/piad105","article-title":"Invasive group A streptococcus in infants less than 1-year of age from 2012 to 2022: a single-center experience.","volume":"13","author":"Nack","year":"2024","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R95-20261009","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/antibiotics10091104","article-title":"Antibiotics in necrotizing soft tissue infections.","volume":"10","author":"Urbina","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R96-20261009","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.2147\/IDR.S279157","article-title":"Beta-haemolytic group A, C and G streptococcal infections in Southern Hungary: a 10-year population-based retrospective survey (2008-2017) and a review of the literature.","volume":"13","author":"Gajd\u00e1cs","year":"2020","journal-title":"Infect Drug Resist"},{"key":"R97-20261009","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","article-title":"High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016.","volume":"8","author":"Lu","year":"2017","journal-title":"Front Microbiol"},{"key":"R98-20261009","doi-asserted-by":"crossref","first-page":"21117","DOI":"10.2807\/1560-7917.ES2015.20.18.21117","article-title":"Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, 2012 to 2013.","volume":"20","author":"Pesola","year":"2015","journal-title":"Euro Surveill"},{"key":"R99-20261009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12887-019-1536-1","article-title":"A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.","volume":"19","author":"Hua","year":"2019","journal-title":"BMC Pediatr"},{"key":"R100-20261009","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/INF.0b013e31826fd4af","article-title":"Group A streptococcus meningitis in children.","volume":"32","author":"de Almeida Torres","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R101-20261009","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0040-1708810","article-title":"Analysis of 11 cases of neonatal invasive Streptococcus pyogenes infection.","volume":"15","author":"Xie","year":"2020","journal-title":"J Pediatr Infect Dis"},{"key":"R102-20261009","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/INF.0000000000002471","article-title":"Molecular characterization of Streptococcus pyogenes causing invasive disease in pediatric population in Spain A 12-year study.","volume":"38","author":"S\u00e1nchez-Encinales","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R103-20261009","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1574884714666190926124714","article-title":"Severe group A and group B streptococcus diseases at a pediatric ICU: are they still sensitive to the penicillins?","volume":"15","author":"Hon","year":"2020","journal-title":"Curr Clin Pharmacol"},{"key":"R104-20261009","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1017\/S0950268813001386","article-title":"Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections.","volume":"142","author":"Zachariadou","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R105-20261009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1574-695X.2010.00652.x","article-title":"Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.","volume":"58","author":"Im\u00f6hl","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R106-20261009","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/JCM.01626-07","article-title":"Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.","volume":"46","author":"Luca-Harari","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R107-20261009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1469-0691.2005.01311.x","article-title":"Group A streptococcus bacteraemia: comparison of adults and children in a single medical centre.","volume":"12","author":"Megged","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R108-20261009","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s10096-016-2704-y","article-title":"Epidemiology of invasive group A streptococcal infections in Norway 2010-2014: a retrospective cohort study.","volume":"35","author":"Naseer","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R109-20261009","first-page":"148","article-title":"Invasive group A streptococcal disease in North Queensland (1996 - 2001).","volume":"119","author":"Norton","year":"2004","journal-title":"Indian J Med Res"},{"key":"R110-20261009","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5694\/j.1326-5377.2007.tb01054.x","article-title":"The epidemiology of invasive group A streptococcal disease in Victoria, Australia.","volume":"186","author":"O\u2019Grady","year":"2007","journal-title":"Med J Aust"},{"key":"R111-20261009","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/JCM.02122-15","article-title":"Epidemiology of invasive group A streptococcal disease in Alaska, 2001 to 2013.","volume":"54","author":"Rudolph","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R112-20261009","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciac720","article-title":"Should linezolid replace clindamycin as the adjunctive antimicrobial of choice in group A streptococcal necrotizing soft tissue infection and toxic shock syndrome? A focused debate.","volume":"76","author":"Cort\u00e9s-Penfield","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R113-20261009","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/cid\/ciab575","article-title":"Patterns of antibiotic nonsusceptibility among invasive group A streptococcus infections\u2014United States, 2006-2017.","volume":"73","author":"Fay","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R114-20261009","doi-asserted-by":"crossref","first-page":"e4592","DOI":"10.1093\/cid\/ciaa976","article-title":"Outcomes of \u03b2-hemolytic streptococcal necrotizing skin and soft-tissue infections and the impact of clindamycin resistance.","volume":"73","author":"Horn","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R115-20261009","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jgar.2020.04.032","article-title":"Emerging erythromycin and clindamycin resistance in group A streptococci: efficacy of linezolid and tedizolid in experimental necrotizing infection.","volume":"22","author":"Bryant","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"R116-20261009","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","article-title":"Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release.","volume":"47","author":"Coyle","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R117-20261009","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bjo.2006.090779","article-title":"Severe invasive beta haemolytic group A streptococcal cellulitis and eyelid necrosis treated with linezolid.","volume":"90","author":"Barry","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R118-20261009","first-page":"5720708","article-title":"Successful treatment of necrotizing fasciitis and streptococcal toxic shock syndrome with the addition of linezolid.","volume":"2017","author":"Rac","year":"2017","journal-title":"Case Rep Infect Dis"},{"key":"R119-20261009","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00006454-200105000-00004","article-title":"Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.","volume":"20","author":"Kaplan","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R120-20261009","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1128\/IAI.66.5.2279-2283.1998","article-title":"Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.","volume":"66","author":"Basma","year":"1998","journal-title":"Infect Immun"},{"key":"R121-20261009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","article-title":"Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.","volume":"27","author":"Negi","year":"2007","journal-title":"J Clin Immunol"},{"key":"R122-20261009","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI116240","article-title":"Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].","volume":"91","author":"Takei","year":"1993","journal-title":"J Clin Invest"},{"key":"R123-20261009","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis.","volume":"67","author":"Parks","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R124-20261009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R125-20261009","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciw871","article-title":"Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity score-matched analysis from 130 US hospitals.","volume":"64","author":"Kadri","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R126-20261009","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0012-3692(15)50887-8","article-title":"Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU.","volume":"130","author":"Mehta","year":"2006","journal-title":"Chest"},{"key":"R127-20261009","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/archdischild-2015-310121","article-title":"Toxic shock syndrome in Australian children.","volume":"101","author":"Chen","year":"2016","journal-title":"Arch Dis Child"},{"key":"R128-20261009","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jpids\/pix099","article-title":"Prospective surveillance of pediatric invasive group A streptococcus infection.","volume":"8","author":"Ching","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R129-20261009","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/606048","article-title":"Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.","volume":"49","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R130-20261009","doi-asserted-by":"crossref","first-page":"e0292311","DOI":"10.1371\/journal.pone.0292311","article-title":"Evaluating antibiotic regimens for streptococcal toxic shock syndrome in children.","volume":"18","author":"Zhang","year":"2023","journal-title":"PLoS One"},{"key":"R131-20261009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0000000000001380","article-title":"Evaluation of early corticosteroid therapy in management of pediatric septic shock in pediatric intensive care patients: a randomized clinical study.","volume":"36","author":"El-Nawawy","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R132-20261009","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","article-title":"Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.","volume":"12","author":"Heming","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R133-20261009","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock.","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"R134-20261009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PCC.0b013e3181d903f6","article-title":"Adjunctive corticosteroid therapy in pediatric severe sepsis: observations from the RESOLVE study.","volume":"12","author":"Zimmerman","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R135-20261009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/BPO.0b013e3182092869","article-title":"Dexamethasone therapy for septic arthritis in children: results of a randomized double-blind placebo-controlled study.","volume":"31","author":"Harel","year":"2011","journal-title":"J Pediatr Orthop"},{"key":"R136-20261009","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.inf.0000091293.32187.7b","article-title":"Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children.","volume":"22","author":"Odio","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R137-20261009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/sur.2010.035","article-title":"Steroids in the treatment of group A streptococcal necrotizing soft tissue infection.","volume":"12","author":"May","year":"2011","journal-title":"Surg Infect (Larchmt)"},{"key":"R138-20261009","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s004310051325","article-title":"Streptococcus pyogenes meningitis: report of a case and review of the literature.","volume":"159","author":"Berner","year":"2000","journal-title":"Eur J Pediatr"},{"key":"R139-20261009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0163-4453(98)93558-7","article-title":"Group A streptococcal meningitis: report of two cases.","volume":"36","author":"Moses","year":"1998","journal-title":"J Infect"},{"key":"R140-20261009","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM199608223350803","article-title":"Invasive group A streptococcal infections in Ontario, Canada. Ontario group A streptococcal study group.","volume":"335","author":"Davies","year":"1996","journal-title":"N Engl J Med"},{"key":"R141-20261009","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3201\/eid0904.020369","article-title":"Risk for severe group A streptococcal disease among patients\u2019 household contacts.","volume":"9","author":"Robinson","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"R142-20261009","doi-asserted-by":"crossref","first-page":"30532","DOI":"10.2807\/1560-7917.ES.2017.22.19.30532","article-title":"Household transmission of invasive group A streptococcus infections in England: a population-based study, 2009, 2011 to 2013.","volume":"22","author":"Mearkle","year":"2017","journal-title":"Euro Surveill"},{"key":"R143-20261009","doi-asserted-by":"crossref","first-page":"ofac244","DOI":"10.1093\/ofid\/ofac244","article-title":"Effectiveness and safety of antibiotic prophylaxis for persons exposed to cases of invasive group A streptococcal disease: a systematic review.","volume":"9","author":"Khan","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R144-20261009","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jama.279.15.1206","article-title":"Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? The Working Group on Prevention of Invasive Group A Streptococcal Infections.","volume":"279","author":"Gerber","year":"1998","journal-title":"JAMA"},{"key":"R145-20261009","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/342692","article-title":"Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention.","volume":"35","author":"Moore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R146-20261009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1155\/2010\/585187","article-title":"Invasive group A streptococcal disease: management and chemoprophylaxis.","volume":"21","author":"Allen","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R148-20261009","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/cid\/ciae524","article-title":"Choosing wisely: effectiveness and safety of antibiotic prophylaxis in close contacts of invasive group A streptococci infection.","volume":"80","author":"Birck","year":"2025","journal-title":"Clin Infect Dis"},{"key":"R149-20261009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jpids\/piu107","article-title":"Management of contacts of patients with severe invasive group A streptococcal infection.","volume":"5","author":"de Almeida Torres","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R150-20261009","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cid\/cit282","article-title":"Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome.","volume":"57","author":"Hamilton","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R151-20261009","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/ciu752","article-title":"Global assessment of invasive group a streptococcus infection risk in household contacts.","volume":"60","author":"Lamagni","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R152-20261009","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3201\/eid1312.070303","article-title":"Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003.","volume":"13","author":"Thigpen","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R153-20261009","doi-asserted-by":"crossref","first-page":"106468","DOI":"10.1016\/j.jinf.2025.106468","article-title":"Antibiotic chemoprophylaxis for close contacts of invasive group A streptococcus in community settings: evidence review.","volume":"90","author":"Watts","year":"2025","journal-title":"J Infect"},{"key":"R154-20261009","doi-asserted-by":"crossref","first-page":"2300609","DOI":"10.2807\/1560-7917.ES.2024.29.17.2300609","article-title":"Outbreak of invasive group A streptococcus disease in a nursing home in Ireland in February 2023 caused by emm type 18.","volume":"29","author":"Carroll","year":"2024","journal-title":"Euro Surveill"},{"key":"R155-20261009","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/cix921","article-title":"Outbreak of invasive infections from subtype emm26.3 group A streptococcus among homeless adults-anchorage, Alaska, 2016-2017.","volume":"66","author":"Mosites","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R157-20261009","doi-asserted-by":"crossref","first-page":"106104","DOI":"10.1016\/j.jinf.2024.01.003","article-title":"Antibiotics to eradicate Streptococcus pyogenes pharyngeal carriage in asymptomatic children and adults: a systematic review.","volume":"88","author":"Hung","year":"2024","journal-title":"J Infect"},{"key":"R158-20261009","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s15010-001-1065-2","article-title":"Meningitis in a girl with recurrent otitis media caused by Streptococcus pyogenes\u2014otitis media has to be treated appropriately.","volume":"29","author":"Steppberger","year":"2001","journal-title":"Infection"},{"key":"R159-20261009","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","article-title":"Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"key":"R160-20261009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00006454-200001000-00009","article-title":"Impact of azithromycin on oropharyngeal carriage of group A streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae.","volume":"19","author":"Morita","year":"2000","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:03:08Z","timestamp":1791518588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005336"}},"subtitle":["The European Society for Pediatric Infectious Disease Guidelines"],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":147,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005336","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"2026-05-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}